nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—ADRB1—obesity	0.228	0.543	CbGaD
Oxprenolol—ADRB2—obesity	0.192	0.457	CbGaD
Oxprenolol—ADRB2—Phenylpropanolamine—obesity	0.118	0.286	CbGbCtD
Oxprenolol—ADRB1—Phenylpropanolamine—obesity	0.116	0.281	CbGbCtD
Oxprenolol—SLC22A2—Cimetidine—obesity	0.0772	0.187	CbGbCtD
Oxprenolol—CYP2D6—Phentermine—obesity	0.031	0.0751	CbGbCtD
Oxprenolol—CYP2D6—Bupropion—obesity	0.0264	0.0639	CbGbCtD
Oxprenolol—CYP2D6—Methamphetamine—obesity	0.0248	0.06	CbGbCtD
Oxprenolol—CYP2D6—Cimetidine—obesity	0.0194	0.0469	CbGbCtD
Oxprenolol—Abdominal colic—Orlistat—obesity	0.00747	0.0789	CcSEcCtD
Oxprenolol—Emotional distress—Diethylpropion—obesity	0.00453	0.0478	CcSEcCtD
Oxprenolol—Psychotic disorder—Methamphetamine—obesity	0.00218	0.0231	CcSEcCtD
Oxprenolol—Psychotic disorder—Benzphetamine—obesity	0.00211	0.0222	CcSEcCtD
Oxprenolol—Psychotic disorder—Phendimetrazine—obesity	0.00192	0.0203	CcSEcCtD
Oxprenolol—Cardiac failure—Phentermine—obesity	0.00165	0.0174	CcSEcCtD
Oxprenolol—Psychotic disorder—Phenylpropanolamine—obesity	0.00164	0.0173	CcSEcCtD
Oxprenolol—Psychotic disorder—Phentermine—obesity	0.00157	0.0166	CcSEcCtD
Oxprenolol—Psychotic disorder—Diethylpropion—obesity	0.00136	0.0144	CcSEcCtD
Oxprenolol—Psychotic disorder—Cimetidine—obesity	0.0013	0.0137	CcSEcCtD
Oxprenolol—Palpitations—Methamphetamine—obesity	0.00119	0.0126	CcSEcCtD
Oxprenolol—Sweating increased—Diethylpropion—obesity	0.00118	0.0124	CcSEcCtD
Oxprenolol—Palpitations—Benzphetamine—obesity	0.00115	0.0121	CcSEcCtD
Oxprenolol—Palpitations—Phendimetrazine—obesity	0.00105	0.011	CcSEcCtD
Oxprenolol—Hyperhidrosis—Benzphetamine—obesity	0.00102	0.0108	CcSEcCtD
Oxprenolol—Insomnia—Methamphetamine—obesity	0.000994	0.0105	CcSEcCtD
Oxprenolol—Dyspepsia—Methamphetamine—obesity	0.000967	0.0102	CcSEcCtD
Oxprenolol—Abnormal dreams—Sibutramine—obesity	0.000967	0.0102	CcSEcCtD
Oxprenolol—Insomnia—Benzphetamine—obesity	0.000958	0.0101	CcSEcCtD
Oxprenolol—Bradycardia—Cimetidine—obesity	0.000936	0.00989	CcSEcCtD
Oxprenolol—Hyperhidrosis—Phendimetrazine—obesity	0.000933	0.00986	CcSEcCtD
Oxprenolol—Dyspepsia—Benzphetamine—obesity	0.000933	0.00985	CcSEcCtD
Oxprenolol—Insomnia—Phendimetrazine—obesity	0.000873	0.00922	CcSEcCtD
Oxprenolol—Palpitations—Phentermine—obesity	0.000855	0.00903	CcSEcCtD
Oxprenolol—Abnormal dreams—Bupropion—obesity	0.000843	0.0089	CcSEcCtD
Oxprenolol—Hypersensitivity—Methamphetamine—obesity	0.000809	0.00855	CcSEcCtD
Oxprenolol—Hypersensitivity—Benzphetamine—obesity	0.000781	0.00824	CcSEcCtD
Oxprenolol—Hypotension—Phenylpropanolamine—obesity	0.000771	0.00814	CcSEcCtD
Oxprenolol—Abdominal pain—Phendimetrazine—obesity	0.000763	0.00806	CcSEcCtD
Oxprenolol—Hypoglycaemia—Orlistat—obesity	0.000752	0.00794	CcSEcCtD
Oxprenolol—Diarrhoea—Methamphetamine—obesity	0.000752	0.00794	CcSEcCtD
Oxprenolol—Insomnia—Phenylpropanolamine—obesity	0.000746	0.00788	CcSEcCtD
Oxprenolol—Palpitations—Diethylpropion—obesity	0.000744	0.00785	CcSEcCtD
Oxprenolol—Hypoglycaemia—Sibutramine—obesity	0.000728	0.00769	CcSEcCtD
Oxprenolol—Dizziness—Methamphetamine—obesity	0.000726	0.00767	CcSEcCtD
Oxprenolol—Diarrhoea—Benzphetamine—obesity	0.000725	0.00766	CcSEcCtD
Oxprenolol—Insomnia—Phentermine—obesity	0.000714	0.00754	CcSEcCtD
Oxprenolol—Dizziness—Benzphetamine—obesity	0.000701	0.0074	CcSEcCtD
Oxprenolol—Dyspepsia—Phentermine—obesity	0.000695	0.00734	CcSEcCtD
Oxprenolol—Psychotic disorder—Sibutramine—obesity	0.000694	0.00733	CcSEcCtD
Oxprenolol—Headache—Methamphetamine—obesity	0.000688	0.00727	CcSEcCtD
Oxprenolol—Arthralgia—Cimetidine—obesity	0.000682	0.0072	CcSEcCtD
Oxprenolol—Fatigue—Phentermine—obesity	0.00068	0.00719	CcSEcCtD
Oxprenolol—Hyperhidrosis—Diethylpropion—obesity	0.000664	0.00701	CcSEcCtD
Oxprenolol—Headache—Benzphetamine—obesity	0.000664	0.00701	CcSEcCtD
Oxprenolol—Diarrhoea—Phendimetrazine—obesity	0.000661	0.00698	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Sibutramine—obesity	0.000649	0.00685	CcSEcCtD
Oxprenolol—Thrombocytopenia—Cimetidine—obesity	0.00064	0.00676	CcSEcCtD
Oxprenolol—Dizziness—Phendimetrazine—obesity	0.000639	0.00674	CcSEcCtD
Oxprenolol—Hypoglycaemia—Bupropion—obesity	0.000634	0.0067	CcSEcCtD
Oxprenolol—Nausea—Benzphetamine—obesity	0.000629	0.00665	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Diethylpropion—obesity	0.000626	0.00661	CcSEcCtD
Oxprenolol—Abdominal pain—Phentermine—obesity	0.000624	0.00659	CcSEcCtD
Oxprenolol—Bronchospasm—Orlistat—obesity	0.000624	0.00659	CcSEcCtD
Oxprenolol—Insomnia—Diethylpropion—obesity	0.000621	0.00656	CcSEcCtD
Oxprenolol—Diplopia—Bupropion—obesity	0.000619	0.00654	CcSEcCtD
Oxprenolol—Sweating increased—Orlistat—obesity	0.000618	0.00653	CcSEcCtD
Oxprenolol—Hypersensitivity—Phenylpropanolamine—obesity	0.000608	0.00642	CcSEcCtD
Oxprenolol—Headache—Phendimetrazine—obesity	0.000605	0.00639	CcSEcCtD
Oxprenolol—Psychotic disorder—Bupropion—obesity	0.000605	0.00639	CcSEcCtD
Oxprenolol—Dyspepsia—Diethylpropion—obesity	0.000604	0.00638	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Cimetidine—obesity	0.000595	0.00629	CcSEcCtD
Oxprenolol—Nausea—Phendimetrazine—obesity	0.000574	0.00606	CcSEcCtD
Oxprenolol—Asthenia—Phentermine—obesity	0.000566	0.00598	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Bupropion—obesity	0.000566	0.00597	CcSEcCtD
Oxprenolol—Fatigue—Cimetidine—obesity	0.000563	0.00595	CcSEcCtD
Oxprenolol—Dizziness—Phenylpropanolamine—obesity	0.000545	0.00576	CcSEcCtD
Oxprenolol—Diarrhoea—Phentermine—obesity	0.00054	0.0057	CcSEcCtD
Oxprenolol—Bronchospasm—Bupropion—obesity	0.000526	0.00556	CcSEcCtD
Oxprenolol—Dizziness—Phentermine—obesity	0.000522	0.00551	CcSEcCtD
Oxprenolol—Sweating increased—Bupropion—obesity	0.000521	0.00551	CcSEcCtD
Oxprenolol—Bradycardia—Sibutramine—obesity	0.0005	0.00528	CcSEcCtD
Oxprenolol—Headache—Phentermine—obesity	0.000494	0.00522	CcSEcCtD
Oxprenolol—Nausea—Phenylpropanolamine—obesity	0.00049	0.00517	CcSEcCtD
Oxprenolol—Hypersensitivity—Cimetidine—obesity	0.000481	0.00508	CcSEcCtD
Oxprenolol—Diarrhoea—Diethylpropion—obesity	0.00047	0.00496	CcSEcCtD
Oxprenolol—Nausea—Phentermine—obesity	0.000469	0.00495	CcSEcCtD
Oxprenolol—Asthenia—Cimetidine—obesity	0.000469	0.00495	CcSEcCtD
Oxprenolol—Dizziness—Diethylpropion—obesity	0.000454	0.0048	CcSEcCtD
Oxprenolol—Diarrhoea—Cimetidine—obesity	0.000447	0.00472	CcSEcCtD
Oxprenolol—Dizziness—Cimetidine—obesity	0.000432	0.00456	CcSEcCtD
Oxprenolol—Headache—Diethylpropion—obesity	0.00043	0.00454	CcSEcCtD
Oxprenolol—Headache—Cimetidine—obesity	0.000409	0.00432	CcSEcCtD
Oxprenolol—Nausea—Diethylpropion—obesity	0.000408	0.00431	CcSEcCtD
Oxprenolol—Hypoglycaemia—Topiramate—obesity	0.000404	0.00427	CcSEcCtD
Oxprenolol—Diplopia—Topiramate—obesity	0.000394	0.00417	CcSEcCtD
Oxprenolol—Palpitations—Orlistat—obesity	0.000391	0.00413	CcSEcCtD
Oxprenolol—Nausea—Cimetidine—obesity	0.000388	0.0041	CcSEcCtD
Oxprenolol—Psychotic disorder—Topiramate—obesity	0.000385	0.00407	CcSEcCtD
Oxprenolol—Palpitations—Sibutramine—obesity	0.000378	0.00399	CcSEcCtD
Oxprenolol—Arthralgia—Sibutramine—obesity	0.000364	0.00385	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Topiramate—obesity	0.00036	0.00381	CcSEcCtD
Oxprenolol—Hyperhidrosis—Orlistat—obesity	0.000349	0.00368	CcSEcCtD
Oxprenolol—Thrombocytopenia—Sibutramine—obesity	0.000342	0.00361	CcSEcCtD
Oxprenolol—Hyperhidrosis—Sibutramine—obesity	0.000337	0.00356	CcSEcCtD
Oxprenolol—Alprenolol—ADRB3—obesity	0.000333	0.0654	CrCbGaD
Oxprenolol—Sweating increased—Topiramate—obesity	0.000332	0.00351	CcSEcCtD
Oxprenolol—Palpitations—Bupropion—obesity	0.00033	0.00348	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Orlistat—obesity	0.000329	0.00347	CcSEcCtD
Oxprenolol—Insomnia—Orlistat—obesity	0.000326	0.00345	CcSEcCtD
Oxprenolol—Hypotension—Sibutramine—obesity	0.000326	0.00345	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Sibutramine—obesity	0.000318	0.00336	CcSEcCtD
Oxprenolol—Dyspepsia—Orlistat—obesity	0.000318	0.00335	CcSEcCtD
Oxprenolol—Arthralgia—Bupropion—obesity	0.000317	0.00335	CcSEcCtD
Oxprenolol—Insomnia—Sibutramine—obesity	0.000316	0.00333	CcSEcCtD
Oxprenolol—Fatigue—Orlistat—obesity	0.000311	0.00328	CcSEcCtD
Oxprenolol—Dyspepsia—Sibutramine—obesity	0.000307	0.00325	CcSEcCtD
Oxprenolol—Thrombocytopenia—Bupropion—obesity	0.000298	0.00315	CcSEcCtD
Oxprenolol—Hyperhidrosis—Bupropion—obesity	0.000294	0.00311	CcSEcCtD
Oxprenolol—Practolol—ADRB1—obesity	0.000286	0.0563	CrCbGaD
Oxprenolol—Pindolol—ADRB3—obesity	0.000286	0.0563	CrCbGaD
Oxprenolol—Abdominal pain—Orlistat—obesity	0.000285	0.00301	CcSEcCtD
Oxprenolol—Hypotension—Bupropion—obesity	0.000284	0.003	CcSEcCtD
Oxprenolol—Bradycardia—Topiramate—obesity	0.000278	0.00293	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Bupropion—obesity	0.000277	0.00293	CcSEcCtD
Oxprenolol—Abdominal pain—Sibutramine—obesity	0.000276	0.00291	CcSEcCtD
Oxprenolol—Insomnia—Bupropion—obesity	0.000275	0.00291	CcSEcCtD
Oxprenolol—Dyspepsia—Bupropion—obesity	0.000268	0.00283	CcSEcCtD
Oxprenolol—Hypersensitivity—Orlistat—obesity	0.000266	0.00281	CcSEcCtD
Oxprenolol—Fatigue—Bupropion—obesity	0.000262	0.00277	CcSEcCtD
Oxprenolol—Metipranolol—ADRB1—obesity	0.000259	0.0509	CrCbGaD
Oxprenolol—Asthenia—Orlistat—obesity	0.000259	0.00273	CcSEcCtD
Oxprenolol—Hypersensitivity—Sibutramine—obesity	0.000257	0.00272	CcSEcCtD
Oxprenolol—Pruritus—Orlistat—obesity	0.000255	0.0027	CcSEcCtD
Oxprenolol—Asthenia—Sibutramine—obesity	0.00025	0.00265	CcSEcCtD
Oxprenolol—Pruritus—Sibutramine—obesity	0.000247	0.00261	CcSEcCtD
Oxprenolol—Diarrhoea—Orlistat—obesity	0.000247	0.00261	CcSEcCtD
Oxprenolol—Abdominal pain—Bupropion—obesity	0.000241	0.00254	CcSEcCtD
Oxprenolol—Diarrhoea—Sibutramine—obesity	0.000239	0.00252	CcSEcCtD
Oxprenolol—Dizziness—Orlistat—obesity	0.000239	0.00252	CcSEcCtD
Oxprenolol—Dizziness—Sibutramine—obesity	0.000231	0.00244	CcSEcCtD
Oxprenolol—Headache—Orlistat—obesity	0.000226	0.00239	CcSEcCtD
Oxprenolol—Hypersensitivity—Bupropion—obesity	0.000224	0.00237	CcSEcCtD
Oxprenolol—Headache—Sibutramine—obesity	0.000219	0.00231	CcSEcCtD
Oxprenolol—Asthenia—Bupropion—obesity	0.000218	0.00231	CcSEcCtD
Oxprenolol—Acebutolol—SLC22A1—obesity	0.000218	0.0429	CrCbGaD
Oxprenolol—Metipranolol—ADRB2—obesity	0.000218	0.0428	CrCbGaD
Oxprenolol—Pruritus—Bupropion—obesity	0.000215	0.00227	CcSEcCtD
Oxprenolol—Nausea—Orlistat—obesity	0.000214	0.00226	CcSEcCtD
Oxprenolol—Palpitations—Topiramate—obesity	0.00021	0.00222	CcSEcCtD
Oxprenolol—Diarrhoea—Bupropion—obesity	0.000208	0.0022	CcSEcCtD
Oxprenolol—Nausea—Sibutramine—obesity	0.000207	0.00219	CcSEcCtD
Oxprenolol—Esmolol—ADRB1—obesity	0.000206	0.0404	CrCbGaD
Oxprenolol—Penbutolol—HTR1B—obesity	0.000203	0.0399	CrCbGaD
Oxprenolol—Arthralgia—Topiramate—obesity	0.000202	0.00214	CcSEcCtD
Oxprenolol—Dizziness—Bupropion—obesity	0.000201	0.00213	CcSEcCtD
Oxprenolol—Headache—Bupropion—obesity	0.000191	0.00201	CcSEcCtD
Oxprenolol—Thrombocytopenia—Topiramate—obesity	0.00019	0.00201	CcSEcCtD
Oxprenolol—Hyperhidrosis—Topiramate—obesity	0.000187	0.00198	CcSEcCtD
Oxprenolol—Hypotension—Topiramate—obesity	0.000181	0.00191	CcSEcCtD
Oxprenolol—Betaxolol—ADRB1—obesity	0.000181	0.0356	CrCbGaD
Oxprenolol—Nausea—Bupropion—obesity	0.000181	0.00191	CcSEcCtD
Oxprenolol—Penbutolol—ADRB1—obesity	0.000179	0.0353	CrCbGaD
Oxprenolol—Atenolol—ADRB1—obesity	0.000179	0.0353	CrCbGaD
Oxprenolol—Musculoskeletal discomfort—Topiramate—obesity	0.000177	0.00187	CcSEcCtD
Oxprenolol—Insomnia—Topiramate—obesity	0.000175	0.00185	CcSEcCtD
Oxprenolol—Bisoprolol—ADRB1—obesity	0.000175	0.0344	CrCbGaD
Oxprenolol—Esmolol—ADRB2—obesity	0.000173	0.034	CrCbGaD
Oxprenolol—Dyspepsia—Topiramate—obesity	0.000171	0.0018	CcSEcCtD
Oxprenolol—Fatigue—Topiramate—obesity	0.000167	0.00177	CcSEcCtD
Oxprenolol—Acebutolol—ADRB1—obesity	0.000166	0.0326	CrCbGaD
Oxprenolol—Propranolol—ADRB3—obesity	0.000156	0.0307	CrCbGaD
Oxprenolol—Abdominal pain—Topiramate—obesity	0.000153	0.00162	CcSEcCtD
Oxprenolol—Betaxolol—ADRB2—obesity	0.000152	0.0299	CrCbGaD
Oxprenolol—Atenolol—ADRB2—obesity	0.000151	0.0297	CrCbGaD
Oxprenolol—Penbutolol—ADRB2—obesity	0.000151	0.0297	CrCbGaD
Oxprenolol—Alprenolol—ADRB1—obesity	0.00015	0.0296	CrCbGaD
Oxprenolol—Bisoprolol—ADRB2—obesity	0.000147	0.0289	CrCbGaD
Oxprenolol—Pindolol—HTR1B—obesity	0.000146	0.0288	CrCbGaD
Oxprenolol—Hypersensitivity—Topiramate—obesity	0.000143	0.00151	CcSEcCtD
Oxprenolol—Metoprolol—ADRB1—obesity	0.00014	0.0275	CrCbGaD
Oxprenolol—Acebutolol—ADRB2—obesity	0.000139	0.0274	CrCbGaD
Oxprenolol—Asthenia—Topiramate—obesity	0.000139	0.00147	CcSEcCtD
Oxprenolol—Pruritus—Topiramate—obesity	0.000137	0.00145	CcSEcCtD
Oxprenolol—Diarrhoea—Topiramate—obesity	0.000133	0.0014	CcSEcCtD
Oxprenolol—Pindolol—ADRB1—obesity	0.000129	0.0254	CrCbGaD
Oxprenolol—Dizziness—Topiramate—obesity	0.000128	0.00135	CcSEcCtD
Oxprenolol—Alprenolol—ADRB2—obesity	0.000126	0.0249	CrCbGaD
Oxprenolol—Headache—Topiramate—obesity	0.000121	0.00128	CcSEcCtD
Oxprenolol—Metoprolol—ADRB2—obesity	0.000118	0.0231	CrCbGaD
Oxprenolol—Nausea—Topiramate—obesity	0.000115	0.00122	CcSEcCtD
Oxprenolol—Pindolol—ADRB2—obesity	0.000109	0.0214	CrCbGaD
Oxprenolol—Propranolol—HTR1B—obesity	7.98e-05	0.0157	CrCbGaD
Oxprenolol—Propranolol—ADRB1—obesity	7.06e-05	0.0139	CrCbGaD
Oxprenolol—Propranolol—ADRB2—obesity	5.94e-05	0.0117	CrCbGaD
Oxprenolol—ADRB2—Signaling Pathways—DRD4—obesity	1.01e-05	0.000149	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—POMC—obesity	1e-05	0.000148	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—F2—obesity	1e-05	0.000148	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PRKCB—obesity	1e-05	0.000148	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PCK1—obesity	9.98e-06	0.000148	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HADH—obesity	9.98e-06	0.000148	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—FADS1—obesity	9.98e-06	0.000148	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CNR1—obesity	9.86e-06	0.000146	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—POMC—obesity	9.81e-06	0.000145	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—F2—obesity	9.78e-06	0.000145	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PRKCB—obesity	9.78e-06	0.000145	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ACP5—obesity	9.71e-06	0.000144	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TCF7L2—obesity	9.69e-06	0.000143	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CNR1—obesity	9.64e-06	0.000143	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AKT2—obesity	9.64e-06	0.000143	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—DRD2—obesity	9.62e-06	0.000142	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CG—obesity	9.57e-06	0.000141	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GCG—obesity	9.52e-06	0.000141	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PTPN1—obesity	9.52e-06	0.000141	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TCF7L2—obesity	9.47e-06	0.00014	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—COMT—obesity	9.47e-06	0.00014	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—G6PD—obesity	9.47e-06	0.00014	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AKT2—obesity	9.43e-06	0.000139	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—DRD2—obesity	9.41e-06	0.000139	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CG—obesity	9.36e-06	0.000138	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HK1—obesity	9.35e-06	0.000138	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SREBF2—obesity	9.35e-06	0.000138	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PPARGC1A—obesity	9.34e-06	0.000138	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GNB3—obesity	9.34e-06	0.000138	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PTPN1—obesity	9.31e-06	0.000138	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GCG—obesity	9.31e-06	0.000138	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—HMOX1—obesity	9.3e-06	0.000137	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CD—obesity	9.26e-06	0.000137	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—POMC—obesity	9.11e-06	0.000135	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GNAS—obesity	9.09e-06	0.000134	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PRL—obesity	9.08e-06	0.000134	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CD—obesity	9.06e-06	0.000134	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LPA—obesity	9.03e-06	0.000134	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—STK11—obesity	8.95e-06	0.000132	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—CCL2—obesity	8.91e-06	0.000132	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—POMC—obesity	8.91e-06	0.000132	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APOB—obesity	8.91e-06	0.000132	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PRL—obesity	8.89e-06	0.000131	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PLG—obesity	8.85e-06	0.000131	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—RHOA—obesity	8.84e-06	0.000131	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LPIN1—obesity	8.84e-06	0.000131	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—STK11—obesity	8.76e-06	0.000129	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AKT2—obesity	8.75e-06	0.000129	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3R1—obesity	8.75e-06	0.000129	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—CCL2—obesity	8.72e-06	0.000129	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PLG—obesity	8.66e-06	0.000128	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOA5—obesity	8.66e-06	0.000128	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—RHOA—obesity	8.65e-06	0.000128	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FOXO3—obesity	8.64e-06	0.000128	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ADRB2—obesity	8.62e-06	0.000127	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AKT2—obesity	8.56e-06	0.000127	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3R1—obesity	8.56e-06	0.000127	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—LPL—obesity	8.5e-06	0.000126	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SOCS1—obesity	8.49e-06	0.000125	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FOXO3—obesity	8.45e-06	0.000125	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CD—obesity	8.41e-06	0.000124	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SOCS3—obesity	8.38e-06	0.000124	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SOCS1—obesity	8.3e-06	0.000123	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—GPX1—obesity	8.3e-06	0.000123	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CLOCK—obesity	8.26e-06	0.000122	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC22A1—obesity	8.26e-06	0.000122	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CD—obesity	8.23e-06	0.000122	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GNB3—obesity	8.21e-06	0.000121	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SOCS3—obesity	8.2e-06	0.000121	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—TYK2—obesity	8.09e-06	0.00012	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CD36—obesity	8.08e-06	0.000119	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CB—obesity	8.07e-06	0.000119	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IGF2—obesity	8.06e-06	0.000119	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SULT2A1—obesity	8.05e-06	0.000119	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GLP1R—obesity	8.05e-06	0.000119	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GNB3—obesity	8.03e-06	0.000119	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—RHOA—obesity	8.03e-06	0.000119	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—GNAS—obesity	7.99e-06	0.000118	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3R1—obesity	7.94e-06	0.000117	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—DPYD—obesity	7.92e-06	0.000117	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—TYK2—obesity	7.92e-06	0.000117	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CB—obesity	7.9e-06	0.000117	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IGF2—obesity	7.89e-06	0.000117	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—RHOA—obesity	7.85e-06	0.000116	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APOB—obesity	7.83e-06	0.000116	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—GNAS—obesity	7.82e-06	0.000116	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3R1—obesity	7.77e-06	0.000115	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—MTHFR—obesity	7.66e-06	0.000113	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APOB—obesity	7.65e-06	0.000113	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCL5—obesity	7.64e-06	0.000113	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PRKAR2B—obesity	7.62e-06	0.000113	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—DCN—obesity	7.57e-06	0.000112	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PPARA—obesity	7.51e-06	0.000111	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCL5—obesity	7.47e-06	0.000111	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—LPL—obesity	7.47e-06	0.00011	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—FOXO1—obesity	7.42e-06	0.00011	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RPS6KB1—obesity	7.4e-06	0.000109	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CPT1A—obesity	7.36e-06	0.000109	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CB—obesity	7.33e-06	0.000108	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—LPL—obesity	7.31e-06	0.000108	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AGT—obesity	7.27e-06	0.000108	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—FOXO1—obesity	7.26e-06	0.000107	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RPS6KB1—obesity	7.24e-06	0.000107	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NAMPT—obesity	7.22e-06	0.000107	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LIPC—obesity	7.17e-06	0.000106	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GCK—obesity	7.17e-06	0.000106	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CB—obesity	7.17e-06	0.000106	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOC3—obesity	7.13e-06	0.000105	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APOE—obesity	7.13e-06	0.000105	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—CAV1—obesity	7.06e-06	0.000104	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—APOA1—obesity	7.05e-06	0.000104	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CETP—obesity	6.92e-06	0.000102	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PRKCD—obesity	6.88e-06	0.000102	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SDC1—obesity	6.84e-06	0.000101	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—HTR2A—obesity	6.74e-06	9.96e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PRKCD—obesity	6.73e-06	9.96e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AKR1C3—obesity	6.73e-06	9.95e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—C3—obesity	6.73e-06	9.95e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SCARB1—obesity	6.63e-06	9.8e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—HTR2A—obesity	6.59e-06	9.74e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—C3—obesity	6.58e-06	9.73e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SREBF1—obesity	6.43e-06	9.51e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CG—obesity	6.43e-06	9.51e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IRS2—obesity	6.4e-06	9.46e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AGT—obesity	6.39e-06	9.45e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APOE—obesity	6.26e-06	9.26e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—LEP—obesity	6.26e-06	9.26e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IRS2—obesity	6.26e-06	9.26e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GOT2—obesity	6.26e-06	9.25e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AGT—obesity	6.25e-06	9.25e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PPARG—obesity	6.21e-06	9.18e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CAV1—obesity	6.21e-06	9.18e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—APOA1—obesity	6.19e-06	9.15e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—LEP—obesity	6.13e-06	9.06e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APOE—obesity	6.13e-06	9.06e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—FASN—obesity	6.12e-06	9.06e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—POMC—obesity	6.12e-06	9.05e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—BCHE—obesity	6.1e-06	9.02e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—INS—obesity	6.09e-06	9e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CAV1—obesity	6.07e-06	8.98e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—APOA1—obesity	6.06e-06	8.95e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—ESR1—obesity	5.98e-06	8.84e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PRKCB—obesity	5.91e-06	8.73e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—F2—obesity	5.91e-06	8.73e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP2E1—obesity	5.88e-06	8.7e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—ESR1—obesity	5.85e-06	8.65e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—BAD—obesity	5.84e-06	8.63e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NQO1—obesity	5.82e-06	8.6e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PRKCB—obesity	5.78e-06	8.54e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—F2—obesity	5.78e-06	8.54e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—BAD—obesity	5.71e-06	8.44e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CD—obesity	5.65e-06	8.36e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CG—obesity	5.65e-06	8.36e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IRS1—obesity	5.59e-06	8.26e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—ALB—obesity	5.58e-06	8.25e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—SLC2A4—obesity	5.58e-06	8.25e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GCG—obesity	5.58e-06	8.25e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CG—obesity	5.53e-06	8.18e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYCS—obesity	5.51e-06	8.14e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IRS1—obesity	5.47e-06	8.08e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GOT1—obesity	5.4e-06	7.99e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GGT1—obesity	5.4e-06	7.99e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—POMC—obesity	5.38e-06	7.96e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—INS—obesity	5.35e-06	7.91e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3R1—obesity	5.34e-06	7.9e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—NOS3—obesity	5.34e-06	7.9e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NCOA1—obesity	5.32e-06	7.87e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—CCL2—obesity	5.26e-06	7.78e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—POMC—obesity	5.26e-06	7.78e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CYP19A1—obesity	5.24e-06	7.76e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—STK11—obesity	5.24e-06	7.76e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—INS—obesity	5.23e-06	7.74e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IGF1—obesity	5.18e-06	7.65e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AKT2—obesity	5.17e-06	7.65e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—CCL2—obesity	5.15e-06	7.61e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IGF1—obesity	5.06e-06	7.49e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AKT2—obesity	5.06e-06	7.48e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CD—obesity	4.97e-06	7.35e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CB—obesity	4.93e-06	7.29e-05	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—PIK3CA—obesity	4.92e-06	7.28e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—SERPINE1—obesity	4.91e-06	7.27e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PTGS2—obesity	4.88e-06	7.22e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—COMT—obesity	4.88e-06	7.21e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CD—obesity	4.86e-06	7.19e-05	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—PIK3CA—obesity	4.81e-06	7.12e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPARGC1A—obesity	4.81e-06	7.11e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GNB3—obesity	4.81e-06	7.11e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—SERPINE1—obesity	4.81e-06	7.11e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—HMOX1—obesity	4.79e-06	7.08e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TYK2—obesity	4.78e-06	7.07e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—RHOA—obesity	4.74e-06	7.01e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—NOS3—obesity	4.69e-06	6.94e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3R1—obesity	4.69e-06	6.94e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GNAS—obesity	4.68e-06	6.92e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TYK2—obesity	4.68e-06	6.91e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—RHOA—obesity	4.64e-06	6.86e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—NOS3—obesity	4.59e-06	6.79e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3R1—obesity	4.59e-06	6.79e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOB—obesity	4.58e-06	6.78e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—PIK3CA—obesity	4.47e-06	6.61e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—LPL—obesity	4.38e-06	6.47e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—PIK3CA—obesity	4.37e-06	6.46e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CB—obesity	4.33e-06	6.4e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MTOR—obesity	4.33e-06	6.4e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—GPX1—obesity	4.27e-06	6.31e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MTOR—obesity	4.24e-06	6.26e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CB—obesity	4.24e-06	6.26e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CD36—obesity	4.16e-06	6.15e-05	CbGpPWpGaD
Oxprenolol—ADRB1—GPCR downstream signaling—AKT1—obesity	4.02e-06	5.94e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—IL6—obesity	3.96e-06	5.85e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—MTHFR—obesity	3.94e-06	5.83e-05	CbGpPWpGaD
Oxprenolol—ADRB2—GPCR downstream signaling—AKT1—obesity	3.93e-06	5.82e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—IL6—obesity	3.87e-06	5.72e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPARA—obesity	3.87e-06	5.72e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MMP9—obesity	3.76e-06	5.57e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AGT—obesity	3.74e-06	5.54e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MMP9—obesity	3.68e-06	5.44e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOE—obesity	3.67e-06	5.43e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MAPK8—obesity	3.66e-06	5.41e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling by GPCR—AKT1—obesity	3.65e-06	5.4e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—CAV1—obesity	3.64e-06	5.38e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—APOA1—obesity	3.63e-06	5.36e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MAPK8—obesity	3.58e-06	5.3e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling by GPCR—AKT1—obesity	3.57e-06	5.28e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—STAT3—obesity	3.35e-06	4.95e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CG—obesity	3.31e-06	4.9e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—STAT3—obesity	3.27e-06	4.84e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PPARG—obesity	3.2e-06	4.73e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—POMC—obesity	3.15e-06	4.66e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—INS—obesity	3.13e-06	4.63e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—MYC—obesity	3.11e-06	4.6e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—TGFB1—obesity	3.1e-06	4.59e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—MYC—obesity	3.04e-06	4.5e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—TGFB1—obesity	3.04e-06	4.49e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—PIK3CA—obesity	3e-06	4.44e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CD—obesity	2.91e-06	4.3e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—ALB—obesity	2.87e-06	4.25e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3R1—obesity	2.75e-06	4.06e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—NOS3—obesity	2.75e-06	4.06e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—PIK3CA—obesity	2.64e-06	3.9e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—PIK3CA—obesity	2.58e-06	3.82e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CB—obesity	2.54e-06	3.75e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PTGS2—obesity	2.51e-06	3.72e-05	CbGpPWpGaD
Oxprenolol—SLC22A2—Metabolism—AKT1—obesity	2.45e-06	3.63e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—IL6—obesity	2.34e-06	3.46e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—IL6—obesity	2.29e-06	3.38e-05	CbGpPWpGaD
Oxprenolol—ADRB1—Signaling Pathways—AKT1—obesity	2.16e-06	3.19e-05	CbGpPWpGaD
Oxprenolol—ADRB2—Signaling Pathways—AKT1—obesity	2.11e-06	3.12e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—PIK3CA—obesity	1.55e-06	2.29e-05	CbGpPWpGaD
Oxprenolol—CYP2D6—Metabolism—AKT1—obesity	1.26e-06	1.87e-05	CbGpPWpGaD
